These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11349271)

  • 21. Impact of a policy to permit the return of donors repeat-reactive to the Abbott PRISM antibody to hepatitis B core antigen assay.
    O'Brien SF; Yi QL; Fan W; Fearon MA; Scalia V; Goldman M
    Transfusion; 2009 Feb; 49(2):271-7. PubMed ID: 19389210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of anti-hepatitis B core antibody-positive donors for living-donor liver transplantation.
    Hwang S; Moon DB; Lee SG; Park KM; Kim KH; Ahn CS; Lee YJ; Chu CW; Yang HS; Cho SH; Oh KB; Ha TY; Min PC
    Transplantation; 2003 Feb; 75(3 Suppl):S45-8. PubMed ID: 12589140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transmission of hepatitis B infection from hepatitis B core antibody--positive livers: background and prevention.
    Rizzetto M
    Liver Transpl; 2001 Jun; 7(6):518-20. PubMed ID: 11443580
    [No Abstract]   [Full Text] [Related]  

  • 24. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
    Manzini P; Girotto M; Borsotti R; Giachino O; Guaschino R; Lanteri M; Testa D; Ghiazza P; Vacchini M; Danielle F; Pizzi A; Valpreda C; Castagno F; Curti F; Magistroni P; Abate ML; Smedile A; Rizzetto M
    Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases.
    Laperche S; Maniez M; Barlet V; El Ghouzzi MH; Le Vacon F; Levayer T; Lunel F; Morel P; Mouillot L; Piquet Y; Pillonel J;
    Transfusion; 2008 Nov; 48(11):2308-14. PubMed ID: 18673347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donors positive for hepatitis B core antibodies in nonliver transplantations.
    Salvadori M; Rosso G; Carta P; Larti A; di Maria L; Bertoni E
    Transplant Proc; 2011; 43(1):277-9. PubMed ID: 21335205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transmission of hepatitis B virus by transplantation of livers from donors positive for antibody to hepatitis B core antigen.
    Castells L; Vargas V; Rodríguez-Frías F; Allende H; Jardí R; Margarit C; Esteban R; Guardia J
    Transplant Proc; 1999 Sep; 31(6):2464-5. PubMed ID: 10500672
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunopathology of acute and chronic viral hepatitis].
    Mayer KH
    Przegl Epidemiol; 1979; 33(3):377-84. PubMed ID: 504700
    [No Abstract]   [Full Text] [Related]  

  • 29. Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance.
    Ghisetti V; Marzano A; Zamboni F; Barbui A; Franchello A; Gaia S; Marchiaro G; Salizzoni M; Rizzetto M
    Liver Transpl; 2004 Mar; 10(3):356-62. PubMed ID: 15004761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of de novo hepatitis B infection from HbcAb-positive donors in living donor liver transplantation.
    Lee KW; Lee DS; Lee HH; Kim SJ; Joh JW; Seo JM; Choe YH; Lee SK
    Transplant Proc; 2004 Oct; 36(8):2311-2. PubMed ID: 15561233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Heterogeneity of host response to hepatitis B virus].
    Sarno EN; Ruzany F; Vieira LM; Landmann J
    Rev Inst Med Trop Sao Paulo; 1982; 24(5):303-9. PubMed ID: 7167709
    [No Abstract]   [Full Text] [Related]  

  • 32. Risk of transmission of hepatitis B virus from anti-HBC positive cadaveric organ donors: a collaborative study.
    De Feo TM; Poli F; Mozzi F; Moretti MP; Scalamogna M;
    Transplant Proc; 2005 Mar; 37(2):1238-9. PubMed ID: 15848681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of testing for antibody to hepatitis B core antigen to prevent transmission of hepatitis B virus in organ and tissue transplantation.
    Kroes AC
    Transplant Proc; 1996 Oct; 28(5):2937-8. PubMed ID: 8908131
    [No Abstract]   [Full Text] [Related]  

  • 34. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L; Strong DM; Tegtmeier G; Stramer S
    Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunopathology of chronic hepatitis.
    Gerber MA
    Monogr Pathol; 1987; (28):54-64. PubMed ID: 3537745
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool.
    Donataccio D; Roggen F; De Reyck C; Verbaandert C; Bodeus M; Lerut J
    Transpl Int; 2006 Jan; 19(1):38-43. PubMed ID: 16359375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoglobulin M hepatitis B core antibody: to titer or not to titer? to use or not to use?
    Gitnick G
    Gastroenterology; 1983 Mar; 84(3):653-5. PubMed ID: 6822334
    [No Abstract]   [Full Text] [Related]  

  • 38. Significance of antibody to hepatitis B core antigen in a hemodialysis unit.
    Wasnich RD; Puapongsakorn R; Seto DS
    West J Med; 1980 Apr; 132(4):279-82. PubMed ID: 7385831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
    Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
    Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and prognostic values of anti-hepatitis B core immunoglobulin M detection in asymptomatic hepatitis B surface antigen carriers.
    Ali HY; Faransawy ZE; Al-Megthab NA
    Saudi Med J; 2002 Jul; 23(7):777-81. PubMed ID: 12174223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.